Omnia SanaPlant Comparison
Cardamom vs Milk Thistle
A side-by-side comparison of two medicinal plants — every documented constituent, action, use, safety note and cited source, assembled automatically from the Omnia Sana database.
At a glance
Cardamom and Milk Thistle: they share 5 indicated uses (arthritis / joint pain, bloating, indigestion, …); 3 pharmacological actions in common.
Evidence face-off — shared uses
| Condition | Cardamom | Milk Thistle | Verdict |
|---|---|---|---|
| Arthritis / joint pain | 1/10 | 5/10 | Stronger for Milk Thistle |
| Bloating | 1/10 | 5/10 | Stronger for Milk Thistle |
| Indigestion | 1/10 | 5/10 | Stronger for Milk Thistle |
| Inflammation (general) | 1/10 | 5/10 | Stronger for Milk Thistle |
| Skin irritation | 1/10 | 5/10 | Stronger for Milk Thistle |
Evidence scores (1–10) are computed from the tier of each cited source. “Comparable” means the two scores are within one point. Follow a score to its detailed sources.
Key Constituents
Seed essential oil dominated by 1,8-cineole and alpha-terpinyl acetate, giving the characteristic aroma and much of the carminative, antimicrobial and antioxidant activity.
Additional antioxidant constituents of the seed.
Pharmacological Actions
Improves glycemic control in type 2 diabetes - lowers fasting blood glucose and HbA1c
Anti-inflammatory and antioxidant; Hepatoprotective / liver support (protects liver cells, antioxidant and antifibrotic)
Digestive support / mild dyspepsia (traditional)
Hepatoprotective / liver support (protects liver cells, antioxidant and antifibrotic); May improve liver enzymes and hepatic fat in non-alcoholic fatty liver disease (NAFLD); Supports liver recovery and 'detox' (traditional framing of the hepatoprotective action)
Traditional & Indicated Uses
inferred from anti-inflammatory action
inferred from digestive action
inferred from digestive action
inferred from antimicrobial action
inferred from anti-inflammatory action
inferred from anti-inflammatory action
inferred from anti-inflammatory action
Improves glycemic control in type 2 diabetes - lowers fasting blood glucose and HbA1c
inferred from anticancer action
Supports liver recovery and 'detox' (traditional framing of the hepatoprotective action)
Digestive support / mild dyspepsia (traditional)
inferred from anti-inflammatory action
Hepatoprotective / liver support (protects liver cells, antioxidant and antifibrotic); May improve liver enzymes and hepatic fat in non-alcoholic fatty liver disease (NAFLD)
inferred from antidiabetic action
Safety, Cautions & Contraindications
Cardamom is generally considered safe for most people when used in culinary amounts. At medicinal doses (supplement form), rare side effects include mild gastrointestinal discomfort and allergic reactions. There are no well-documented serious drug interactions at culinary doses. Cardamom may mildly lower blood pressure — caution if combined with antihypertensive medications. Some sources suggest potential gallstone formation with very high doses, as cardamom may stimulate bile flow. Avoid therapeutic doses during pregnancy until more safety data are available; culinary use is considered safe. Allergy to other Zingiberaceae (ginger, turmeric) may indicate cross-reactivity risk (Korikanthimath and Hiremath, 2002).
Duke (2002) provides clinical support (score 2) for cardamom as a cholagogue, antiviral agent, and appetite stimulant. Commission E and the German PDR (PHR) approve it for loss of appetite and bronchitis (score 2). The essential oil shows antispasmodic and carminative activity. Dose: 1.5 g ground fruit or equivalent preparation three times daily. Duke rates cardamom as generally safe (++), with no significant contraindications at therapeutic doses (Duke, 2002).
Very well tolerated, even at high doses; the main effects are mild gastrointestinal upset (nausea, loose stools). As a member of the daisy family (Asteraceae), it can cause allergic reactions in sensitive people.
Has a low potential for drug interactions (little effect on liver CYP enzymes), but use caution with medicines that have a narrow therapeutic window. Human pregnancy data are limited, so use cautiously.
External Ids
Botanical Description
Large, rhizomatous perennial herb with tall, reed-like leafy stems (pseudostems) formed by overlapping leaf sheaths, arising from a stout underground rhizome. Small, pale flowers with a violet-veined white lip are borne on separate trailing panicles that grow along the ground from the base of the plant. The fruit is a small, ridged, pale green three-sided capsule (the cardamom pod) containing numerous dark, aromatic seeds.[1]
Robust biennial (occasionally annual) thistle (Asteraceae), 30-150 cm tall. Leaves are glossy dark green with distinctive white marbled veining (the 'milk' of legend), spiny-margined and deeply lobed. Large, solitary, purple-pink thistle-type flower heads are surrounded by spiny bracts, followed by shiny, mottled brown-black seeds - the part used.[12]
Habitat
Native to the moist evergreen forests of the Western Ghats of southern India and Sri Lanka; cultivated in warm, humid, shaded tropical conditions, notably in India, Guatemala and Sri Lanka.[1]
Native to the Mediterranean region, now naturalised worldwide on disturbed, sunny ground - roadsides, waste places and dry pastures - and widely cultivated commercially for its seed.[12]
Harvesting
The unripe green pods are hand-picked just before full maturity, then carefully dried (traditionally in the shade or by gentle heat) to preserve the green colour and aromatic oil; the pods are typically used whole or the seeds removed and ground just before use.
Seed heads are harvested once fully dry (late summer), and the seeds (fruit) are threshed out.[12]
Traditional Uses
Cardamom has a long Ayurvedic, Middle Eastern and Asian tradition as a warming digestive carminative for indigestion and bloating, a remedy for respiratory complaints such as asthma and bronchitis, and a valued spice for tea, coffee and cooking.[1]
Milk thistle has a very long European folk-medicine tradition, documented since antiquity, as a liver tonic, and its seed extract, standardised to the flavonolignan complex silymarin, is one of the most extensively studied herbal hepatoprotectants. Modern research supports antioxidant, anti-inflammatory and liver-protective activity, with growing interest in metabolic/blood-sugar effects.[12, 13]
Preparations
Dosage
The WHO monograph on Semen Cardamomi gives an average DAILY dosage of 1.5 g of the drug, or equivalent preparations; for tincture, a daily dosage equivalent to 12 g. Note the 1.5 g is a daily total, not a per-dose amount. Educational reference only, not a prescription.
References
Lookalikes Review
Drug Class Interactions
Not documented
References & Sources
- Ashokkumar, K., Murugan, M., Dhanya, M.K. and Warkentin, T.D (2019) 'Botany, traditional uses, phytochemistry and biological activities of cardamom [Elettaria cardamomum (L.) Maton] - A critical review', Journal of Ethnopharmacology, 246, pp. 112244. doi:10.1016/j.jep.2019.112244 Meta-analysis / review
https://doi.org/10.1016/j.jep.2019.112244 - Jamal, A., Javed, K., Aslam, M. and Jafri, M.A (2006) 'Gastroprotective effect of cardamom, Elettaria cardamomum Maton. fruits in rats', Journal of Ethnopharmacology, 103(2), pp. 149-153. doi:10.1016/j.jep.2005.07.016 Preclinical
https://doi.org/10.1016/j.jep.2005.07.016 - Yahyazadeh, R., Ghasemzadeh Rahbardar, M., Razavi, B.M., Karimi, G. and Hosseinzadeh, H (2021) 'The effect of Elettaria cardamomum (cardamom) on the metabolic syndrome: Narrative review', Iranian Journal of Basic Medical Sciences, 24(11), pp. 1462-1469. doi:10.22038/IJBMS.2021.54417.12228 Meta-analysis / review
https://doi.org/10.22038/IJBMS.2021.54417.12228 - Cardenas Garza, G.R., Elizondo Luevano, J.H., Bazaldua Rodriguez, A.F., Chavez Montes, A., Perez Hernandez, R.A. and Martinez Delgado, A.J (2021) 'Benefits of Cardamom (Elettaria cardamomum (L.) Maton) and Turmeric (Curcuma longa L.) Extracts for Their Applications as Natural Anti-Inflammatory Adjuvants', Plants, 10(9), pp. 1908. doi:10.3390/plants10091908 Preclinical
https://doi.org/10.3390/plants10091908 - Sreedharan, S., Nair, V. and Cisneros-Zevallos, L (2023) 'Protective Role of Phenolic Compounds from Whole Cardamom (Elettaria cardamomum (L.) Maton) against LPS-Induced Inflammation in Colon and Macrophage Cells', Nutrients, 15(13), pp. 2965. doi:10.3390/nu15132965 Preclinical
https://doi.org/10.3390/nu15132965 - Almeer, R.S., Alnasser, M., Aljarba, N. and AlBasher, G.I (2021) 'Effects of Green cardamom (Elettaria cardamomum Maton) and its combination with cyclophosphamide on Ehrlich solid tumors', BMC Complementary Medicine and Therapies, 21(1), pp. 133. doi:10.1186/s12906-021-03305-2 Preclinical
https://doi.org/10.1186/s12906-021-03305-2 - Almohammed, H.I., Alkhaibari, A.M. and Alanazi, A.D (2022) 'Antiparasitic effects of Elettaria cardamomum L. essential oil and its main compounds, 1,8-Cineole alone and in combination with albendazole against Echinococcus granulosus protoscoleces', Saudi Journal of Biological Sciences, 29(4), pp. 2811-2818. doi:10.1016/j.sjbs.2022.01.005 Preclinical
https://doi.org/10.1016/j.sjbs.2022.01.005 - Pavarino, M., Marengo, A., Cagliero, C., Bicchi, C., Rubiolo, P. and Sgorbini, B (2023) 'Elettaria cardamomum (L.) Maton Essential Oil: An Interesting Source of Bioactive Specialized Metabolites as Inhibitors of Acetylcholinesterase and Butyrylcholinesterase', Plants, 12(19), pp. 3463. doi:10.3390/plants12193463 Preclinical
https://doi.org/10.3390/plants12193463 - Masoumi-Ardakani, Y., Mahmoudvand, H., Mirzaei, A., Esmaeilpour, K., Ghazvini, H. and Khalifeh, S (2017) 'The effect of Elettaria cardamomum extract on anxiety-like behavior in a rat model of post-traumatic stress disorder', Biomedicine & Pharmacotherapy, 87, pp. 489-495. doi:10.1016/j.biopha.2016.12.116 Preclinical
https://doi.org/10.1016/j.biopha.2016.12.116 - Delgadillo-Puga, C., Torre-Villalvazo, I., Carino-Cervantes, Y.Y., Garcia-Luna, C., Soberanes-Chavez, P. and de Gortari, P (2023) 'Cardamom (Elettaria cardamomum (L.) Maton) Seeds Intake Increases Energy Expenditure and Reduces Fat Mass in Mice by Modulating Neural Circuits That Regulate Adipose Tissue Lipolysis and Mitochondrial Oxidative Metabolism in Liver and Skeletal Muscle', International Journal of Molecular Sciences, 24(4), pp. 3909. doi:10.3390/ijms24043909 Preclinical
https://doi.org/10.3390/ijms24043909 - World Health Organization (2009) 'Semen Cardamomi'. Available at: https://iris.who.int/items/6418d8af-5200-4e6b-9bf5-004f3aa62a37 Traditional / reference
https://iris.who.int/items/6418d8af-5200-4e6b-9bf5-004f3aa62a37 - Bhilave, M.P., Bhosale, S.V. and Nadaf, S.B (2013) 'Evaluation of antibacterial activity of cardamom seeds of Elettaria cardamomum', 4(1), pp. 66--69. Traditional / reference
https://scholar.google.com/scholar?q=Evaluation%20of%20antibacterial%20activity%20of%20cardamom%20seeds%20of%20Elettaria%20cardamomum - Jamal, A., Javed, K., Aslam, M. and Jafri, M.A (2006) 'Gastroprotective effect of cardamom, Elettaria cardamomum (Maton) Fruits in Rats', 103(2), pp. 149--153. doi:10.1016/j.jep.2005.09.040 Traditional / reference
https://doi.org/10.1016/j.jep.2005.09.040 - Korikanthimath, V.S. and Hiremath, G.M (2002) 'Cardamom (Elettaria cardamomum Maton)', pp. 144--157. Traditional / reference
https://scholar.google.com/scholar?q=Cardamom%20%28Elettaria%20cardamomum%20Maton%29 - Royal Botanic Gardens, Kew (n.d.) 'Elettaria cardamomum (L.) Maton'. Available at: https://powo.science.kew.org/taxon/urn:lsid:http://ipni.org:names:796793-1 Traditional / reference
https://powo.science.kew.org/taxon/urn:lsid:http://ipni.org:names:796793-1 - Verma, S.K., Jain, V. and Katewa, S.S (2009) 'Blood pressure lowering, fibrinolysis enhancing and antioxidant activities of cardamom (Elettaria cardamomum)', 46(6), pp. 503--506. Traditional / reference
https://scholar.google.com/scholar?q=Blood%20pressure%20lowering%2C%20fibrinolysis%20enhancing%20and%20antioxidant%20activities%20of%20cardamom%20%28Elettaria%20cardamomum%29 - Duke, J.A (2002) 'Handbook of Medicinal Herbs, Second Edition'. Traditional / reference
https://scholar.google.com/scholar?q=Handbook%20of%20Medicinal%20Herbs%2C%20Second%20Edition
- Abenavoli, L., Izzo, A.A., Milic, N., Cicala, C., Santini, A. and Capasso, R (2018) 'Milk thistle (Silybum marianum): A concise overview on its chemistry, pharmacological, and nutraceutical uses in liver diseases', Phytotherapy Research, 32(11), pp. 2202-2213. doi:10.1002/ptr.6171 Meta-analysis / review
https://doi.org/10.1002/ptr.6171 - Bahmani, M., Shirzad, H., Rafieian, S. and Rafieian-Kopaei, M (2015) 'Silybum marianum: Beyond Hepatoprotection', Journal of Evidence-Based Complementary & Alternative Medicine, 20(4), pp. 292-301. doi:10.1177/2156587215571116 Meta-analysis / review
https://doi.org/10.1177/2156587215571116 - Wang, X., Zhang, Z. and Wu, S (2020) 'Health Benefits of Silybum marianum: Phytochemistry, Pharmacology, and Applications', Journal of Agricultural and Food Chemistry, 68(42), pp. 11644-11664. doi:10.1021/acs.jafc.0c04791 Meta-analysis / review
https://doi.org/10.1021/acs.jafc.0c04791 - Marmouzi, I., Bouyahya, A., Ezzat, S.M., El Jemli, M. and Kharbach, M (2020) 'The food plant Silybum marianum (L.) Gaertn.: Phytochemistry, Ethnopharmacology and clinical evidence', Journal of Ethnopharmacology, 265, pp. 113303. doi:10.1016/j.jep.2020.113303 Meta-analysis / review
https://doi.org/10.1016/j.jep.2020.113303 - Greenlee, H., Abascal, K., Yarnell, E. and Ladas, E (2007) 'Clinical applications of Silybum marianum in oncology', Integrative Cancer Therapies, 6(2), pp. 158-165. doi:10.1177/1534735407301727 Meta-analysis / review
https://doi.org/10.1177/1534735407301727 - Shaker, E., Mahmoud, H. and Mnaa, S (2009) 'Silymarin, the antioxidant component and Silybum marianum extracts prevent liver damage', Food and Chemical Toxicology, 48(3), pp. 803-806. doi:10.1016/j.fct.2009.12.011 Preclinical
https://doi.org/10.1016/j.fct.2009.12.011 - Flora, K., Hahn, M., Rosen, H. and Benner, K (1998) 'Milk thistle (Silybum marianum) for the therapy of liver disease', American Journal of Gastroenterology, 93(2), pp. 139-143. doi:10.1111/j.1572-0241.1998.00139.x Meta-analysis / review
https://doi.org/10.1111/j.1572-0241.1998.00139.x - Csupor, D., Csorba, A. and Hohmann, J (2016) 'Recent advances in the analysis of flavonolignans of Silybum marianum', Journal of Pharmaceutical and Biomedical Analysis, 130, pp. 301-317. doi:10.1016/j.jpba.2016.05.034 Meta-analysis / review
https://doi.org/10.1016/j.jpba.2016.05.034 - Ball, K.R. and Kowdley, K.V (2005) 'A review of Silybum marianum (milk thistle) as a treatment for alcoholic liver disease', Journal of Clinical Gastroenterology, 39(6), pp. 520-528. doi:10.1097/01.mcg.0000165668.79530.a0 Meta-analysis / review
https://doi.org/10.1097/01.mcg.0000165668.79530.a0 - Tajmohammadi, A., Razavi, B.M. and Hosseinzadeh, H (2018) 'Silybum marianum (milk thistle) and its main constituent, silymarin, as a potential therapeutic plant in metabolic syndrome: A review', Phytotherapy Research, 32(10), pp. 1933-1949. doi:10.1002/ptr.6153 Meta-analysis / review
https://doi.org/10.1002/ptr.6153 - Ghahfarrokhi, S.H., Heidari-Soureshjani, S., Sherwin, C.M.T. and Azadegan-Dehkordi, Z (2024) 'Efficacy and Mechanisms of Silybum marianum, Silymarin, and Silibinin on Rheumatoid Arthritis and Osteoarthritis Symptoms: A Systematic Review', Current Rheumatology Reviews, 20(4), pp. 414-425. doi:10.2174/0115733971266397231122080247 Meta-analysis / review
https://doi.org/10.2174/0115733971266397231122080247 - Soleimani, V., Delghandi, P.S., Moallem, S.A. and Karimi, G (2019) 'Safety and toxicity of silymarin, the major constituent of milk thistle extract: An updated review', Phytotherapy Research. doi:10.1002/ptr.6361 Randomized trial
https://doi.org/10.1002/ptr.6361 - Fallah, M., Davoodvandi, A., Nikmanzar, S., Aghili, S., Mirazimi, S.M.A., Aschner, M., Rashidian, A., Hamblin, M.R., Chamanara, M., Naghsh, N. and Mirzaei, H (2021) 'Silymarin (milk thistle extract) as a therapeutic agent in gastrointestinal cancer', Biomedicine & Pharmacotherapy. doi:10.1016/j.biopha.2021.112024 Preclinical
https://doi.org/10.1016/j.biopha.2021.112024 - Voroneanu, L., Nistor, I., Dumea, R., Apetrii, M. and Covic, A (2016) 'Silymarin in Type 2 Diabetes Mellitus: A Systematic Review and Meta-Analysis of Randomized Controlled Trials', Journal of Diabetes Research. doi:10.1155/2016/5147468 Meta-analysis / review
https://doi.org/10.1155/2016/5147468 - Zhou, J., Chen, Y., Yu, J., Li, T., Lu, Z., Chen, Y., Zhang, X. and Ye, F (2021) 'The efficacy of novel metabolic targeted agents and natural plant drugs for nonalcoholic fatty liver disease treatment: A PRISMA-compliant network meta-analysis of randomized controlled trials', Medicine (Baltimore), 100(12). doi:10.1097/MD.0000000000024884 Meta-analysis / review
https://doi.org/10.1097/MD.0000000000024884 - Fuhr, U., Beckmann-Knopp, S., Jetter, A., Lueck, H. and Mengs, U (2007) 'The effect of silymarin on oral nifedipine pharmacokinetics', Planta Medica, 73(14), pp. 1429-1435. doi:10.1055/s-2007-990256 Randomized trial
https://doi.org/10.1055/s-2007-990256 - Hadi, A., Pourmasoumi, M., Mohammadi, H., Symonds, M. and Miraghajani, M (2018) 'The effects of silymarin supplementation on metabolic status and oxidative stress in patients with type 2 diabetes mellitus: A systematic review and meta-analysis of clinical trials', Complementary Therapies in Medicine, 41, pp. 311-319. doi:10.1016/j.ctim.2018.08.010 Meta-analysis / review
https://doi.org/10.1016/j.ctim.2018.08.010
Generated automatically from the Omnia Sana plant database and its cited sources. For educational purposes only — not medical advice. Always consult a qualified practitioner before using medicinal plants.